Coexistence of BCR/ABL1-positive Chronic Myeloid Leukemia and JAK2 V617F-mutated Myelofibrosis Successfully Treated With Dasatinib and Ruxolitinib

Blood Res. 2019 Mar;54(1):77-79. doi: 10.5045/br.2019.54.1.77. Epub 2019 Mar 21.